1107 related articles for article (PubMed ID: 19237699)
1. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
Magaña SM; Matiello M; Pittock SJ; McKeon A; Lennon VA; Rabinstein AA; Shuster E; Kantarci OH; Lucchinetti CF; Weinshenker BG
Neurology; 2009 Feb; 72(8):712-7. PubMed ID: 19237699
[TBL] [Abstract][Full Text] [Related]
2. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Takahashi T; Fujihara K; Nakashima I; Misu T; Miyazawa I; Nakamura M; Watanabe S; Shiga Y; Kanaoka C; Fujimori J; Sato S; Itoyama Y
Brain; 2007 May; 130(Pt 5):1235-43. PubMed ID: 17449477
[TBL] [Abstract][Full Text] [Related]
3. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
Min JH; Kim HJ; Kim BJ; Lee KW; Sunwoo IN; Kim SM; Kim BJ; Kim SH; Park MS; Waters P; Vincent A; Sung JJ; Lee KH
Mult Scler; 2009 Sep; 15(9):1069-76. PubMed ID: 19625331
[TBL] [Abstract][Full Text] [Related]
4. Acute disseminating encephalomyelitis in neuromyelitis optica: closing the floodgates.
Eichel R; Meiner Z; Abramsky O; Gotkine M
Arch Neurol; 2008 Feb; 65(2):267-71. PubMed ID: 18268199
[TBL] [Abstract][Full Text] [Related]
5. CNS aquaporin-4 autoimmunity in children.
McKeon A; Lennon VA; Lotze T; Tenenbaum S; Ness JM; Rensel M; Kuntz NL; Fryer JP; Homburger H; Hunter J; Weinshenker BG; Krecke K; Lucchinetti CF; Pittock SJ
Neurology; 2008 Jul; 71(2):93-100. PubMed ID: 18509092
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of NMO according to brain MRI findings].
Shimizu Y
Brain Nerve; 2010 Sep; 62(9):933-43. PubMed ID: 20844304
[TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.
Pittock SJ; Weinshenker BG; Lucchinetti CF; Wingerchuk DM; Corboy JR; Lennon VA
Arch Neurol; 2006 Jul; 63(7):964-8. PubMed ID: 16831965
[TBL] [Abstract][Full Text] [Related]
8. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
9. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.
Kim W; Kim SH; Lee SH; Li XF; Kim HJ
Mult Scler; 2011 Sep; 17(9):1107-12. PubMed ID: 21543554
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
[TBL] [Abstract][Full Text] [Related]
11. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
[TBL] [Abstract][Full Text] [Related]
12. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis and treatment of posterior reversible encephalopathy syndrome after neuromyelitis optica spectrum disorder: a case report and literature review.
Yang B; Guo L; Yang X; Yu N
BMC Neurol; 2022 Dec; 22(1):493. PubMed ID: 36539740
[TBL] [Abstract][Full Text] [Related]
14. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Hamnik SE; Hacein-Bey L; Biller J; Gruener G; Jay W
Semin Ophthalmol; 2008; 23(3):191-200. PubMed ID: 18432545
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica and non organ-specific autoimmunity.
Pittock SJ; Lennon VA; de Seze J; Vermersch P; Homburger HA; Wingerchuk DM; Lucchinetti CF; Zéphir H; Moder K; Weinshenker BG
Arch Neurol; 2008 Jan; 65(1):78-83. PubMed ID: 18195142
[TBL] [Abstract][Full Text] [Related]
17. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
[TBL] [Abstract][Full Text] [Related]
18. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
Misu T; Fujihara K; Itoyama Y
Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
[TBL] [Abstract][Full Text] [Related]
20. Aquaporin-4 autoantibodies in a paraneoplastic context.
Pittock SJ; Lennon VA
Arch Neurol; 2008 May; 65(5):629-32. PubMed ID: 18474738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]